Meritage Portfolio Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Meritage Portfolio Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-38,465	Closed	-$4.25M	–	203
2016 Q3	$4.25M	Sell	38,465 -1,377	-3%	-$182K	0.47%	111
2016 Q2	$5.8M	Sell	39,842 -590	-1%	-$83.7K	0.65%	49
2016 Q1	$5.79M	Sell	40,432 -555	-1%	-$78.8K	0.66%	53
2015 Q4	$6.33M	Sell	40,987 -230	-0.6%	-$33.6K	0.71%	38
2015 Q3	$5.89M	Buy	41,217 +9,915	+32%	+$1.39M	0.68%	45
2015 Q2	$4.5M	Buy	+31,302	New	+$4.46M	0.47%	123

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Meritage Portfolio Management's TARO Position: Q4 2016 in Review

Meritage Portfolio Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2016, closing a stake of 38,465 shares — an estimated $4.25M sold.

Meritage Portfolio Management first reported a position in TARO in Q2 2015 and held it in 6 quarters. The position peaked at $6.33M in Q4 2015. 151 funds tracked by Wall St. Rank hold TARO as of Q4 2016.

Meritage Portfolio Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2016 after selling out during the quarter.
Meritage Portfolio Management sold 38,465 Taro Pharmaceutical Industries Ltd. shares in Q4 2016, an estimated $4.25M.
Meritage Portfolio Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2015 and held it in 6 quarters.
Meritage Portfolio Management's Taro Pharmaceutical Industries Ltd. position peaked at $6.33M in Q4 2015.
151 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2016.

Based on Meritage Portfolio Management's 13F filing for Q4 2016, filed 24 Jan 2017.